Lymphoma Research Foundation Announces New Scientific Advisory Board Members

Share Article

Three lymphoma experts join world renowned scientific leadership committee.

News Image

The Lymphoma Research Foundation (LRF) has announced the election of three experts in the field of lymphoma research to its Scientific Advisory Board (SAB):

Sandeep Dave, MD is Associate Professor and Director of the Molecular Genetics and Genomics Program in the Duke Cancer Institute at Duke University in Durham, North Carolina. His work is focused on the application of high throughput technologies, including microarrays and massively parallel sequencing to identify new therapeutic targets, as well as markers for diagnosis and prognosis in patients with leukemias and lymphomas. Dr. Dave holds a Master of Science in Biomedical Engineering and did his medical training through the combined MD/MBA program at Northwestern University in Illinois, where he also completed his residency before taking a fellowship at the National Institutes of Health. He is a member of the Lymphoma Research Foundation’s Mantle Cell Lymphoma Consortium and has served as a reviewer for LRF grant programs.

Laura Pasqualucci, MD is Associate Professor of Clinical Pathology and Cell Biology for Columbia University’s Department of Pathology and Institute for Cancer Genetics, Herbert Irving Comprehensive Cancer Center in New York. Her clinical and research interests include the molecular genetics of lymphoma, with a particular interest in diffuse large B-cell lymphoma. Dr. Pasqualucci received her MD from the University of Perugia Medical School in Italy, and completed her residency at Perugia’s Institute of Hematology and Bone Marrow Transplantation Unit before holding fellowships at the Freie Universität Berlin in Germany and Columbia University in New York. She has been a member of the Lymphoma Research Foundation’s Panel of Scientific Advisors since 2011 and has served as a reviewer for multiple LRF grant cycles. Dr. Pasqualucci currently serves on the Editorial Board of Blood, a prominent peer-reviewed medical journal.

Eduardo M. Sotomayor, MD is the Susan and John Sykes Endowed Chair in Hematologic Malignancies at Moffitt Cancer Center, and Professor of Oncologic Sciences and of Pathology and Cell Biology at the University of South Florida College of Medicine in Tampa, Florida. His research interests include immunobiology and immunotherapy of B-cell malignancies, with special emphasis on the design of novel lymphoma vaccines. His clinical interest lies particularly with mantle cell lymphoma. Dr. Sotomayor received his MD from Federico Villarreal National University School of Medicine in Peru, before completing his residency at the Jackson Memorial Medical Center of the University of Miami School of Medicine in Florida. He trained as a Medical Oncologist at Johns Hopkins University in Baltimore, Maryland. Dr. Sotomayor is a member of the Lymphoma Research Foundation’s Mantle Cell Lymphoma Consortium and has received multiple grants from LRF and currently he is the recipient of three NIH grants.

“We look forward to the contributions of these talented physicians and researchers as members of our world-renowned Scientific Advisory Board,” said LRF Chief Executive Officer Diane Blum.

Comprised of the world’s leading lymphoma researchers and oncologists, the Scientific Advisory Board formulates the LRF research portfolio, seeking out the most innovative and promising lymphoma research projects for support. The 45-member SAB reviews grant proposals and makes recommendations regarding research priorities and funding to the Foundation Board of Directors. The SAB also evaluates the progress of on-going research projects and guides the strategic direction of the Foundation’s research programs and consortia.

The new members’ five-year terms began July 1, 2013.

“Members of the Lymphoma Research Foundation’s Scientific Advisory Board are leaders in blood cancer research and lymphoma care; the expertise of the newly elected Scientific Advisory Board members will complement that of the SAB and have a meaningful impact on the lymphoma community,” said Dr. John P. Leonard, Chair of LRF’s Scientific Advisory Board, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology and Associate Dean for Clinical Research at Weill Cornell Medical College. “I look forward to working with the newest SAB members as we continue to make strides to eradicate lymphoma."

For more information about the Lymphoma Research Foundation’s research program, visit

About the Lymphoma Research Foundation

The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $55 million in lymphoma-specific research.

For additional information on LRF’s research, education and services, please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Peggy Ann Torney
Follow us on
Visit website